CClinicalTrials.gg
CompletedNCT01961050Updated Feb 19, 2016

Preventing FAS/ARND in Russian Children

An interventional study of Dual-Focused Brief Physician Intervention (DFBPI) and Services as usual in Fetal Alcohol Syndrome (FAS), Fetal Alcohol Spectrum Disorders and Alcohol Abuse in Pregnancy, sponsored by University of Oklahoma. Completed at 2 sites in Russian Federation. Open to female participants aged 18 Years to 44 Years. Per ClinicalTrials.gov, last updated 2016-02-19.

Sponsored by University of Oklahoma · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
767
Allocation
Randomized
Ages
18 Years to 44 Years
Sex
Female
01

Study summary

The purpose of this study is to evaluate an intervention aimed at reducing risk for alcohol-exposed pregnancies and preventing Fetal Alcohol Spectrum Disorders in Russian children. The study will determine whether physicians, trained in a dual-focused brief motivational intervention and monitored for performance, can foster greater change in knowledge, health beliefs, alcohol use, and alcohol-exposed pregnancy risk in Russian women who are at risk than standard care.

Read the detailed description

The study is a two-arm, 20-site, site-randomized, controlled trial testing an intervention to reduce risk for alcohol-exposed pregnancies in at-risk women (at-risk drinking childbearing age women who are heterosexually active, and not consistently using contraception). The trial will assess feasibility of a dual-focused (i.e. contraception use-drinking reduction) brief physician intervention (DFBPI) and determine whether physicians, trained in DFBPI and monitored for compliance, can foster greater reduction of women's risk behaviors compared to standard care. The intervention is specifically designed to be deliverable routinely by Obstetrics and Gynecology physicians(OB/GYN) to large numbers of women at women's clinics.

02

Conditions studied

  • Fetal Alcohol Syndrome (FAS)
  • Fetal Alcohol Spectrum Disorders
  • Alcohol Abuse in Pregnancy

Keywords

  • alcohol
  • pregnancy
  • fetal exposure
  • prevention
  • FAS
  • Alcohol-Related Neurodevelopmental Disorder (ARND)
03

In context

Fetal Alcohol Spectrum Disorders

63 studies on the registry are indexed under Fetal Alcohol Spectrum Disorders; 13 are open to participants now.

This study's enrollment of 767 is above the median of 70 across 55 interventional studies indexed under Fetal Alcohol Spectrum Disorders.

Browse Fetal Alcohol Spectrum Disorders studies →

Lead sponsor

University of Oklahoma is the lead sponsor of 424 studies on the registry; 99 are open to participants now.

Of its 42 completed or terminated interventional studies of FDA-regulated products, 16 (38%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • nonpregnant women
  • childbearing age (between 18 and 44 years of age)
  • fertile
  • at risk for an alcohol-exposed pregnancy: drinking at-risk (4 or more drinks on one occasion or more than 7 drinks per week)in the last 3 months and report having unprotected intercourse at least once in the last 6 months

Exclusion criteria

Exclusion Criteria:

  • unable comprehend interview questions
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
767 participants (actual)

Study arms

  • Experimental
    Intervention

    Dual-Focused Brief Physician Intervention (DFBPI)

    Behavioral: Dual-Focused Brief Physician Intervention (DFBPI)

  • Other
    Standard care

    Services as usual including standard OB/GYN clinic visits; no experimental intervention is provided.

    Other: Services as usual

Interventions

  • BehavioralDual-Focused Brief Physician Intervention (DFBPI)

    The DFBPI is incorporated in OB/GYN clinic visit. The intervention consists of two brief (5 to 10 minutes) manualized counseling segments delivered face-to-face by an OB/GYN in the context of two clinic visits.

  • OtherServices as usual

    Active Comparator: Standard OB/GYN clinic visits that include OB/GYN services as usual.

06

What researchers measure

Primary outcomes

  1. Change from Baseline Alcohol-Exposed Pregnancy (AEP) risk at 3 months

    Interviews are conducted at the baseline and follow-up assessments at 3, 6, and 12 months after the baseline to assess self-reported alcohol consumption, sexual activity, and contraception use to identify AEP risk.

    Time frame: 3 months

  2. Change from Baseline Alcohol-Exposed Pregnancy (AEP) risk at 6 months

    Interviews are conducted at the baseline and follow-up assessments at 3, 6, and 12 months after the baseline to assess self-reported alcohol consumption, sexual activity, and contraception use to identify AEP risk.

    Time frame: 6 months

  3. Change from Baseline Alcohol-Exposed Pregnancy (AEP) risk at 12 months

    Interviews are conducted at the baseline and follow-up assessments at 3, 6, and 12 months after the baseline to assess self-reported alcohol consumption, sexual activity, and contraception use to identify AEP risk.

    Time frame: 12 months

Secondary outcomes

  1. Changes in alcohol consumption from baseline

    Interviews assessed self-reported quantity/frequency of alcohol consumption and frequency of binge drinking and a detailed alcohol consumption report was received utilizing the Time Line Follow Back (TLFB) measure.

    Time frame: 3 months, 6 months, and 12 months follow-up

  2. Changes in knowledge about Fetal Alcohol Syndrome (FAS) from baseline

    A survey measure assessed knowledge about FAS

    Time frame: 3 months, 6 months, and 12 months follow-up

  3. Changes in Health beliefs and attitudes from baseline

    A survey measure assessed attitudes and health beliefs related to alcohol use during pregnancy

    Time frame: 3 months, 6 months, and 12 months follow-up

07

Study locations

2 sites
  • Women's Clinics
    Nizhniy Novgorod, 603950, Russian Federation
  • Women's clinics
    St. Peterburg, 199034, Russian Federation
08

References and documents

Publications

  • Balachova T, Bonner BL, Chaffin M, Isurina G, Shapkaitz V, Tsvetkova L, Volkova E, Grandilevskaya I, Skitnevskaya L, Knowlton N. Brief FASD prevention intervention: physicians' skills demonstrated in a clinical trial in Russia. Addict Sci Clin Pract. 2013 Jan 8;8(1):1. doi: 10.1186/1940-0640-8-1. PubMed 23294846 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01961050
Lead sponsor
University of Oklahoma
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA), Fogarty International Center of the National Institute of Health, St. Petersburg State Pavlov Medical University, Nizhny Novgorod State Pedagogical University
Responsible party
Sponsor
First posted
Oct 11, 2013
Start date
Sep 2007
Primary completion
Jul 2015
Completion
Jul 2015
Last update
Feb 19, 2016

Study contacts

Tatiana Balachova, PhD
principal investigator · University of Oklahoma

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion